NYSE: OGNOrganon & Co Stock Ownership - Who owns Organon & Co?
Insider buying vs selling
Have Organon & Co insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ferreira Juan Camilo Arjona | CMO;Head | 2026-08-11 | 4,134 | $13.62 | $56.31kSell |
| Juliana Papa Drinane | Head | 2026-08-05 | 14,761 | $13.57 | $200.31kSell |
| Lynette Holzbaur | SVP and Corporate Controller | 2026-05-06 | 26,448 | $13.35 | $353.08kBuy |
| Lynette Holzbaur | SVP and Corporate Controller | 2026-05-06 | 26,448 | $13.35 | $353.08kSell |
| Vittorio Nisita | Head of Global Business Svcs | 2026-03-31 | 2,875 | $5.70 | $16.39kSell |
| Juliana Papa Drinane | Interim Head of Mfg Supply | 2026-03-31 | 3,451 | $5.70 | $19.67kSell |
| Vittorio Nisita | Head of Global Business Svcs | 2026-03-31 | 1,578 | $5.70 | $8.99kSell |
| Kirke Weaver | Gen. Counsel Corp. Secy. | 2026-03-31 | 1,767 | $5.70 | $10.07kSell |
| Matthew M. Walsh | Chief Financial Officer | 2026-03-31 | 7,380 | $5.70 | $42.07kSell |
| Aaron Falcione | Chief Human Resources Officer | 2026-03-31 | 2,306 | $5.70 | $13.14kSell |
OGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when OGN insiders and whales buy or sell their stock.
OGN Shareholders
What type of owners hold Organon & Co stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Kevin Ali | 0.11% | 282,731 | $3.91M | Insider |
| Matthew M. Walsh | 0.08% | 212,746 | $2.94M | Insider |
| Joseph T. Morrissey Jr. | 0.05% | 123,122 | $1.70M | Insider |
| Rachel A. Stahler | 0.04% | 116,105 | $1.61M | Insider |
| Aaron Falcione | 0.04% | 101,431 | $1.40M | Insider |
| Kirke Weaver | 0.04% | 92,639 | $1.28M | Insider |
| Carrie Smith Cox | 0.03% | 90,338 | $1.25M | Insider |
| Vittorio Nisita | 0.03% | 70,619 | $976.66k | Insider |
| Daniel Karp | 0.03% | 69,547 | $961.84k | Insider |
| Susanne Fiedler | 0.02% | 53,113 | $734.55k | Insider |
OGN vs General Drug Manufacturer Stocks
Organon & Co Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.